johnlead· 199 weeks ago johnlead johnlead· 199 weeks ago barrybruce
Under a Creative Commons license open accessAbstract Background Immune checkpoint inhibitors (ICIs) that against programmed cell death protein-1 (PD-1) and its ligand PD-L1 have been approved as a promising treatment of many human cancers. However, the responses to these ICIs were limited in pa...
All fieldsTitleAbstractKeywordsAuthorsAffiliationsDoiFull TextReferences Open AccessFeature PaperReview by Judith S. Weis 1,*and Karl H. Palmquist 2 1 Department of Biological Science, Rutgers University, Newark, NJ 07102, USA 2 The Rockefeller University, New York, NY 10065, USA ...
The limited license granted in this Agreement does not give you any right to, and you may not, sell, copy (except under applicable legal exceptions such as the “private copy” exception under applicable law), loan, lease, distribute, disassemble, decompile, decrypt, hack, derive source code...